{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T06:56:52Z","timestamp":1792565812466,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T00:00:00Z","timestamp":1424908800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00204-015-1480-2","type":"journal-article","created":{"date-parts":[[2015,2,25]],"date-time":"2015-02-25T05:08:32Z","timestamp":1424840912000},"page":"575-588","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Synthetic cajanin stilbene acid derivatives inhibit c-MYC in breast cancer cells"],"prefix":"10.1007","volume":"90","author":[{"given":"Onat","family":"Kadioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Wiench","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuangang","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Efferth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,26]]},"reference":[{"issue":"6046","key":"1480_CR1","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/318533a0","volume":"318","author":"JM Adams","year":"1985","unstructured":"Adams JM, Harris AW, Pinkert CA et al (1985) The c-MYC oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318(6046):533\u2013538","journal-title":"Nature"},{"issue":"Suppl","key":"1480_CR2","first-page":"71","volume":"15","author":"L Addou-Klouche","year":"2012","unstructured":"Addou-Klouche L, Adelaide J, Cornen S et al (2012) Integrated genomic analysis of breast cancers. Balkan J Med Genet BJMG 15(Suppl):71\u201374. doi: 10.2478\/v10034-012-0023-x","journal-title":"Balkan J Med Genet BJMG"},{"issue":"2","key":"1480_CR3","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrc721","volume":"2","author":"S Ali","year":"2002","unstructured":"Ali S, Coombes RC (2002) Endocrine-responsive breast cancer and strategies for combating resistance. Nat Rev Cancer 2(2):101\u2013112. doi: 10.1038\/nrc721","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"1480_CR4","first-page":"737","volume":"6","author":"LT Amundadottir","year":"1995","unstructured":"Amundadottir LT, Johnson MD, Merlino G, Smith GH, Dickson RB (1995) Synergistic interaction of transforming growth factor alpha and c-MYC in mouse mammary and salivary gland tumorigenesis. Cell Growth Differ Mol Biol J Am Assoc Cancer Res 6(6):737\u2013748","journal-title":"Cell Growth Differ Mol Biol J Am Assoc Cancer Res"},{"issue":"8","key":"1480_CR5","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S0960-9822(01)00154-3","volume":"11","author":"I Arnold","year":"2001","unstructured":"Arnold I, Watt FM (2001) c-MYC activation in transgenic mouse epidermis results in mobilization of stem cells and differentiation of their progeny. Curr Biol CB 11(8):558\u2013568","journal-title":"Curr Biol CB"},{"issue":"5","key":"1480_CR6","doi-asserted-by":"crossref","first-page":"e97076","DOI":"10.1371\/journal.pone.0097076","volume":"9","author":"A Bhardwaj","year":"2014","unstructured":"Bhardwaj A, Rosen D, Liu M et al (2014) suppression of Akt-mTOR pathway\u2014a novel component of oncogene induced DNA damage response barrier in breast tumorigenesis. PLoS ONE 9(5):e97076. doi: 10.1371\/journal.pone.0097076","journal-title":"PLoS ONE"},{"issue":"4984","key":"1480_CR7","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1126\/science.2251503","volume":"250","author":"TK Blackwell","year":"1990","unstructured":"Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN, Weintraub H (1990) Sequence-specific DNA binding by the c-MYC protein. Science 250(4984):1149\u20131151","journal-title":"Science"},{"issue":"Suppl 1","key":"1480_CR8","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1677\/erc.1.00993","volume":"12","author":"AJ Butt","year":"2005","unstructured":"Butt AJ, McNeil CM, Musgrove EA, Sutherland RL (2005) Downstream targets of growth factor and oestrogen signalling and endocrine resistance: the potential roles of c-MYC, cyclin D1 and cyclin E. Endocr Relat Cancer 12(Suppl 1):S47\u2013S59. doi: 10.1677\/erc.1.00993","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"1480_CR9","first-page":"1071","volume":"34","author":"S Byler","year":"2014","unstructured":"Byler S, Goldgar S, Heerboth S et al (2014) Genetic and epigenetic aspects of breast cancer progression and therapy. Anticancer Res 34(3):1071\u20131077","journal-title":"Anticancer Res"},{"issue":"13","key":"1480_CR10","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/bioinformatics\/bti473","volume":"21","author":"K Cartharius","year":"2005","unstructured":"Cartharius K, Frech K, Grote K et al (2005) MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21(13):2933\u20132942. doi: 10.1093\/bioinformatics\/bti473","journal-title":"Bioinformatics"},{"issue":"2","key":"1480_CR11","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1002\/ijc.27675","volume":"132","author":"F Castro","year":"2013","unstructured":"Castro F, Dirks WG, Fahnrich S, Hotz-Wagenblatt A, Pawlita M, Schmitt M (2013) High-throughput SNP-based authentication of human cell lines. Int J Cancer 132(2):308\u2013314. doi: 10.1002\/ijc.27675","journal-title":"Int J Cancer"},{"issue":"10","key":"1480_CR12","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1586\/14737140.8.10.1689","volume":"8","author":"Y Chen","year":"2008","unstructured":"Chen Y, Olopade OI (2008) MYC in breast tumor progression. Expert Rev Anticancer Ther 8(10):1689\u20131698. doi: 10.1586\/14737140.8.10.1689","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"1480_CR13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.molcel.2005.12.016","volume":"21","author":"AS Cheng","year":"2006","unstructured":"Cheng AS, Jin VX, Fan M et al (2006) Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. Mol Cell 21(3):393\u2013404. doi: 10.1016\/j.molcel.2005.12.016","journal-title":"Mol Cell"},{"issue":"47","key":"1480_CR14","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1038\/sj.onc.1206937","volume":"22","author":"R Clarke","year":"2003","unstructured":"Clarke R, Liu MC, Bouker KB et al (2003) Antiestrogen resistance in breast cancer and the role of estrogen receptor signaling. Oncogene 22(47):7316\u20137339. doi: 10.1038\/sj.onc.1206937","journal-title":"Oncogene"},{"issue":"3","key":"1480_CR15","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/jpet.110.170555","volume":"335","author":"DM Clausen","year":"2010","unstructured":"Clausen DM, Guo J, Parise RA et al (2010) In vitro cytotoxicity and in vivo efficacy, pharmacokinetics, and metabolism of 10074-G5, a novel small-molecule inhibitor of c-MYC\/MAX dimerization. J Pharmaco Exp Ther 335(3):715\u2013727. doi: 10.1124\/jpet.110.170555","journal-title":"J Pharmaco Exp Ther"},{"issue":"2","key":"1480_CR16","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/84691","volume":"7","author":"CM D\u2019Cruz","year":"2001","unstructured":"D\u2019Cruz CM, Gunther EJ, Boxer RB et al (2001) c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations. Nat Med 7(2):235\u2013239. doi: 10.1038\/84691","journal-title":"Nat Med"},{"key":"1480_CR17","unstructured":"Eichhorn T (2011) Molecular biology, pharmacogenomics and bioinformatics of natural compounds and synthetic compounds for cancer therapy. Ph.D. Thesis. Ruperto-Carola University of Heidelberg, Germany"},{"issue":"13","key":"1480_CR18","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1073\/pnas.83.13.4834","volume":"83","author":"C Escot","year":"1986","unstructured":"Escot C, Theillet C, Lidereau R et al (1986) Genetic alteration of the c-MYC protooncogene (MYC) in human primary breast carcinomas. Proc Natl Acad Sci USA 83(13):4834\u20134838","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"1480_CR19","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S1097-2765(00)80367-6","volume":"4","author":"DW Felsher","year":"1999","unstructured":"Felsher DW, Bishop JM (1999) Reversible tumorigenesis by MYC in hematopoietic lineages. Mol Cell 4(2):199\u2013207","journal-title":"Mol Cell"},{"issue":"11","key":"1480_CR20","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.chembiol.2008.09.011","volume":"15","author":"AV Follis","year":"2008","unstructured":"Follis AV, Hammoudeh DI, Wang H, Prochownik EV, Metallo SJ (2008) Structural rationale for the coupled binding and unfolding of the c-MYC oncoprotein by small molecules. Chem Biol 15(11):1149\u20131155. doi: 10.1016\/j.chembiol.2008.09.011","journal-title":"Chem Biol"},{"issue":"1","key":"1480_CR21","first-page":"21","volume":"3","author":"M Guerin","year":"1988","unstructured":"Guerin M, Barrois M, Terrier MJ, Spielmann M, Riou G (1988) Overexpression of either c-MYC or c-erbB-2\/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis. Oncog Res 3(1):21\u201331","journal-title":"Oncog Res"},{"issue":"14","key":"1480_CR22","doi-asserted-by":"crossref","first-page":"3286","DOI":"10.1002\/j.1460-2075.1994.tb06630.x","volume":"13","author":"EA Harrington","year":"1994","unstructured":"Harrington EA, Bennett MR, Fanidi A, Evan GI (1994) c-MYC-induced apoptosis in fibroblasts is inhibited by specific cytokines. EMBO J 13(14):3286\u20133295","journal-title":"EMBO J"},{"issue":"6","key":"1480_CR23","first-page":"535","volume":"6","author":"J Jonkers","year":"2004","unstructured":"Jonkers J, Berns A (2004) Oncogene addiction: sometimes a temporary slavery. Cancer Cell 6(6):535\u2013538. doi: 10.1016\/j.ccr.2004.12.002","journal-title":"Cancer Cell"},{"key":"1480_CR24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/1471-2164-12-507","volume":"12","author":"MA Kallio","year":"2011","unstructured":"Kallio MA, Tuimala JT, Hupponen T et al (2011) Chipster: user-friendly analysis software for microarray and other high-throughput data. BMC Genom 12:507. doi: 10.1186\/1471-2164-12-507","journal-title":"BMC Genom"},{"issue":"3","key":"1480_CR25","doi-asserted-by":"crossref","first-page":"e1798","DOI":"10.1371\/journal.pone.0001798","volume":"3","author":"J Kim","year":"2008","unstructured":"Kim J, Lee JH, Iyer VR (2008) Global identification of Myc target genes reveals its direct role in mitochondrial biogenesis and its E-box usage in vivo. PLoS ONE 3(3):e1798. doi: 10.1371\/journal.pone.0001798","journal-title":"PLoS ONE"},{"issue":"5","key":"1480_CR26","doi-asserted-by":"crossref","first-page":"e62766","DOI":"10.1371\/journal.pone.0062766","volume":"8","author":"B Kim","year":"2013","unstructured":"Kim B, Fatayer H, Hanby AM et al (2013) Neoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancer. PLoS ONE 8(5):e62766. doi: 10.1371\/journal.pone.0062766","journal-title":"PLoS ONE"},{"issue":"6","key":"1480_CR27","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1210\/endo.130.6.1375896","volume":"130","author":"JL Kirkland","year":"1992","unstructured":"Kirkland JL, Murthy L, Stancel GM (1992) Progesterone inhibits the estrogen-induced expression of c-fos messenger ribonucleic acid in the uterus. Endocrinology 130(6):3223\u20133230. doi: 10.1210\/endo.130.6.1375896","journal-title":"Endocrinology"},{"issue":"8","key":"1480_CR28","doi-asserted-by":"crossref","first-page":"e2987","DOI":"10.1371\/journal.pone.0002987","volume":"3","author":"EA Musgrove","year":"2008","unstructured":"Musgrove EA, Sergio CM, Loi S et al (2008) Identification of functional networks of estrogen- and c-MYC-responsive genes and their relationship to response to tamoxifen therapy in breast cancer. PLoS ONE 3(8):e2987. doi: 10.1371\/journal.pone.0002987","journal-title":"PLoS ONE"},{"issue":"2","key":"1480_CR29","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0092-8674(02)01284-9","volume":"112","author":"SK Nair","year":"2003","unstructured":"Nair SK, Burley SK (2003) X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors. Cell 112(2):193\u2013205","journal-title":"Cell"},{"issue":"2\u20135","key":"1480_CR30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jsbmb.2004.12.006","volume":"93","author":"RI Nicholson","year":"2005","unstructured":"Nicholson RI, Hutcheson IR, Britton D et al (2005) Growth factor signalling networks in breast cancer and resistance to endocrine agents: new therapeutic strategies. J Steroid Biochem Mol Biol 93(2\u20135):257\u2013262. doi: 10.1016\/j.jsbmb.2004.12.006","journal-title":"J Steroid Biochem Mol Biol"},{"key":"1480_CR31","doi-asserted-by":"crossref","first-page":"e95","DOI":"10.1038\/oncsis.2014.8","volume":"3","author":"TZ Parris","year":"2014","unstructured":"Parris TZ, Kovacs A, Hajizadeh S et al (2014) Frequent MYC coamplification and DNA hypomethylation of multiple genes on 8q in 8p11\u2013p12-amplified breast carcinomas. Oncogenesis 3:e95. doi: 10.1038\/oncsis.2014.8","journal-title":"Oncogenesis"},{"key":"1480_CR32","doi-asserted-by":"crossref","unstructured":"Pavesi G, Pesole G (2006) Using Weeder for the discovery of conserved transcription factor binding sites. Current protocols in bioinformatics\/editoral board, Andreas D Baxevanis et al. Chapter 2: Unit 2 11. doi: 10.1002\/0471250953.bi0211s15","DOI":"10.1002\/0471250953.bi0211s15"},{"issue":"10","key":"1480_CR33","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nrc904","volume":"2","author":"S Pelengaris","year":"2002","unstructured":"Pelengaris S, Khan M, Evan G (2002a) c-MYC: more than just a matter of life and death. Nat Rev Cancer 2(10):764\u2013776. doi: 10.1038\/nrc904","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"1480_CR34","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0092-8674(02)00738-9","volume":"109","author":"S Pelengaris","year":"2002","unstructured":"Pelengaris S, Khan M, Evan GI (2002b) Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 109(3):321\u2013334","journal-title":"Cell"},{"issue":"2","key":"1480_CR35","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/jhg.2012.127","volume":"58","author":"KV Plourde","year":"2013","unstructured":"Plourde KV, Labrie Y, Desjardins S et al (2013) Analysis of ZNF350\/ZBRK1 promoter variants and breast cancer susceptibility in non-BRCA1\/2 French Canadian breast cancer families. J Hum Genet 58(2):59\u201366. doi: 10.1038\/jhg.2012.127","journal-title":"J Hum Genet"},{"issue":"16","key":"1480_CR36","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.ejca.2005.08.017","volume":"41","author":"R Ponzielli","year":"2005","unstructured":"Ponzielli R, Katz S, Barsyte-Lovejoy D, Penn LZ (2005) Cancer therapeutics: targeting the dark side of Myc. Eur J Cancer 41(16):2485\u20132501. doi: 10.1016\/j.ejca.2005.08.017","journal-title":"Eur J Cancer"},{"issue":"3","key":"1480_CR37","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0168-9525(92)90196-B","volume":"8","author":"GC Prendergast","year":"1992","unstructured":"Prendergast GC, Ziff EB (1992) A new bind for Myc. Trends Genet TIG 8(3):91\u201396","journal-title":"Trends Genet TIG"},{"issue":"36","key":"1480_CR38","doi-asserted-by":"crossref","first-page":"4984","DOI":"10.1038\/sj.onc.1204459","volume":"20","author":"O Schuldiner","year":"2001","unstructured":"Schuldiner O, Benvenisty N (2001) A DNA microarray screen for genes involved in c-MYC and N-MYC oncogenesis in human tumors. Oncogene 20(36):4984\u20134994. doi: 10.1038\/sj.onc.1204459","journal-title":"Oncogene"},{"issue":"7012","key":"1480_CR39","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nature03043","volume":"431","author":"CM Shachaf","year":"2004","unstructured":"Shachaf CM, Kopelman AM, Arvanitis C et al (2004) MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature 431(7012):1112\u20131117. doi: 10.1038\/nature03043","journal-title":"Nature"},{"issue":"46","key":"1480_CR40","doi-asserted-by":"crossref","first-page":"30608","DOI":"10.1074\/jbc.273.46.30608","volume":"273","author":"Y Shang","year":"1998","unstructured":"Shang Y, Baumrucker CR, Green MH (1998) c-MYC is a major mediator of the synergistic growth inhibitory effects of retinoic acid and interferon in breast cancer cells. J Biol Chem 273(46):30608\u201330613","journal-title":"J Biol Chem"},{"issue":"1","key":"1480_CR41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/prot.21082","volume":"65","author":"SF Sousa","year":"2006","unstructured":"Sousa SF, Fernandes PA, Ramos MJ (2006) Protein-ligand docking: current status and future challenges. Proteins 65(1):15\u201326. doi: 10.1002\/prot.21082","journal-title":"Proteins"},{"issue":"1","key":"1480_CR42","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/ijc.10269","volume":"99","author":"M Venditti","year":"2002","unstructured":"Venditti M, Iwasiow B, Orr FW, Shiu RP (2002) c-MYC gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells. Int J Cancer 99(1):35\u201342","journal-title":"Int J Cancer"},{"issue":"3","key":"1480_CR43","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1128\/JVI.42.3.773-779.1982","volume":"42","author":"B Vennstrom","year":"1982","unstructured":"Vennstrom B, Sheiness D, Zabielski J, Bishop JM (1982) Isolation and characterization of c-MYC, a cellular homolog of the oncogene (v-MYC) of avian myelocytomatosis virus strain 29. J Virol 42(3):773\u2013779","journal-title":"J Virol"},{"issue":"2","key":"1480_CR44","doi-asserted-by":"crossref","first-page":"R220","DOI":"10.1186\/bcr975","volume":"7","author":"YH Wang","year":"2005","unstructured":"Wang YH, Liu S, Zhang G et al (2005) Knockdown of c-MYC expression by RNAi inhibits MCF-7 breast tumor cells growth in vitro and in vivo. Breast Cancer Res BCR 7(2):R220\u2013R228. doi: 10.1186\/bcr975","journal-title":"Breast Cancer Res BCR"},{"issue":"9","key":"1480_CR45","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1158\/1535-7163.MCT-07-0005","volume":"6","author":"H Wang","year":"2007","unstructured":"Wang H, Hammoudeh DI, Follis AV et al (2007) Improved low molecular weight Myc-Max inhibitors. Mol Cancer Ther 6(9):2399\u20132408. doi: 10.1158\/1535-7163.MCT-07-0005","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"1480_CR46","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1021\/jf103970b","volume":"59","author":"N Wu","year":"2011","unstructured":"Wu N, Kong Y, Fu Y et al (2011) In vitro antioxidant properties, DNA damage protective activity, and xanthine oxidase inhibitory effect of cajaninstilbene acid, a stilbene compound derived from pigeon pea [Cajanus cajan (L.) Millsp.] leaves. J Agric Food Chem 59(1):437\u2013443. doi: 10.1021\/jf103970b","journal-title":"J Agric Food Chem"},{"issue":"2","key":"1480_CR47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.molimm.2012.04.011","volume":"52","author":"Y Yan","year":"2012","unstructured":"Yan Y, Zhang GX, Williams MS et al (2012) TCR stimulation upregulates MS4a4B expression through induction of AP-1 transcription factor during T cell activation. Mol Immunol 52(2):71\u201378. doi: 10.1016\/j.molimm.2012.04.011","journal-title":"Mol Immunol"},{"issue":"1","key":"1480_CR48","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.bmcl.2012.10.013","volume":"23","author":"JL Yap","year":"2013","unstructured":"Yap JL, Wang H, Hu A et al (2013) Pharmacophore identification of c-MYC inhibitor 10074-G5. Bioorg Med Chem Lett 23(1):370\u2013374. doi: 10.1016\/j.bmcl.2012.10.013","journal-title":"Bioorg Med Chem Lett"},{"issue":"12","key":"1480_CR49","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.cellsig.2011.07.001","volume":"23","author":"A Ziv-Av","year":"2011","unstructured":"Ziv-Av A, Taller D, Attia M et al (2011) RTVP-1 expression is regulated by SRF downstream of protein kinase C and contributes to the effect of SRF on glioma cell migration. Cell Signal 23(12):1936\u20131943. doi: 10.1016\/j.cellsig.2011.07.001","journal-title":"Cell Signal"},{"issue":"14","key":"1480_CR50","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.phymed.2010.04.005","volume":"17","author":"YG Zu","year":"2010","unstructured":"Zu YG, Liu XL, Fu YJ, Wu N, Kong Y, Wink M (2010) Chemical composition of the SFE-CO extracts from Cajanus cajan (L.) Huth and their antimicrobial activity in vitro and in vivo. Phytomedicine Int J Phytotherapy Phytopharm 17(14):1095\u20131101. doi: 10.1016\/j.phymed.2010.04.005","journal-title":"Phytomedicine Int J Phytotherapy Phytopharm"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-015-1480-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00204-015-1480-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00204-015-1480-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T08:19:42Z","timestamp":1598775582000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00204-015-1480-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,26]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["1480"],"URL":"https:\/\/doi.org\/10.1007\/s00204-015-1480-2","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,26]]}}}